Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
US10406208B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2015 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Aug 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a therapeutic agent for ophthalmic disease containing thymosin beta 4. The present invention is more effective in reducing xerophthalmia than an ophthalmic solution containing cyclosporine A, is less irritant to eyes than conventional ophthalmic solutions and is physiochemically safe.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.